Prof. Sabine Costagliola «Our next Frontiers in Biomedicine seminar will be given by Dr. Sabine Costagliola. For a long time, her lab has focused on the role of the ...

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

Iron-dependent ferroptosis, a non-apoptotic cell death mechanism, is gaining attention for its role in immune suppression.

A 66-year-old man was referred to our dermatology clinic for a 6-year history of a progressive pruritic rash, refractory to ...

The author of the ‘Leonard List’ that highlights emerging hematologic research to be presented at annual ASH meetings is also ...

Innate Pharma continues its slow rollout of promising clinical candidates, with 2025 set for key milestones. Read more about ...

Chugai Pharmaceutical has launched Lunsumio (mosunetuzumab) in Japan for patients with relapsed or refractory follicular ...

Chugai introduces Lunsumio for intravenous infusion, a bispecific antibody to treat relapsed or refractory follicular lymphoma in Japan: Tokyo Thursday, March 20, 2025, 11:00 Hrs ...

Zhang, X. and Zeng, X. (2025) Diagnostic Challenges and Multidisciplinary Management Strategies for Manicure-Induced ...

The EC has granted expanded approval to BMS' Breyanzi, to treat adults with relapsed or refractory follicular lymphoma (FL).

The measles virus attacks long-lived immune cells, reducing antibody-mediated protection from other infectious diseases and ...